Neoadjuvant chemotherapy in malignant pleural mesothelioma

Lung Cancer

Volumn 49, Issue SUPPL. 1, 2005, Pages

  Stahel, Rolf ^a   Weder, Walter ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GEMCITABINE;

ADVANCED CANCER; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; NAUSEA; PLEURA MESOTHELIOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION INJURY; RECURRENT CANCER; SHORT SURVEY; SURGICAL MORTALITY; SURVIVAL TIME; THROMBOCYTOPENIA;

EID: 20444401199     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.03.014     Document Type: Article

References (5)

1. C. Taverna, R. Stahel, S. Bodis, E.W. Russi, and W. Weder Malignant pleural mesothelioma: trimodality therapy at a single center Ann Oncol 11 2000 123
2. M.J. Byrne, J.A. Davidson, A.W. Musk, J. Dewar, G. van Hazel, and M. Buck Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study J Clin Oncol 17 1999 25 30
3. W. Weder, P. Kestenholz, C. Taverna, S. Bodis, D. Lardinois, and M. Jerman Neoadjuvant chemotherapy in malignant pleural mesothelioma J Clin Oncol 22 2004 3451 3457
4. Stahel RA, Weder W, Ballabeni P, Betticher D, Schmid R, Stupp R, et al. Swiss Group for Clinical Cancer Research (SAKK), Swiss Institute for Applied Cancer Research, Switzerland. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma (MPM): a multicenter phase II trial of the SAKK. ASCO; 2004.
5. V.W. Rusch, K. Rosenzweig, E. Venkatraman, L. Leon, A. Raben, and L. Harrison A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma J Thorac Cardiovasc Surg 122 2001 788 795